Response to letter regarding article, "endovascular stroke therapy: tirofiban is associated with risk of fatal intracerebral hemorrhage and poor outcome"

Stroke. 2013 Sep;44(9):e113. doi: 10.1161/STROKEAHA.113.002354. Epub 2013 Aug 8.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Cerebral Hemorrhage / chemically induced*
  • Female
  • Fibrinolytic Agents / adverse effects*
  • Humans
  • Male
  • Platelet Aggregation Inhibitors / adverse effects*
  • Stroke / therapy*
  • Thrombectomy*
  • Tyrosine / analogs & derivatives*

Substances

  • Fibrinolytic Agents
  • Platelet Aggregation Inhibitors
  • Tyrosine